(Press-News.org) National Institutes of Health, National Science Foundation, Starr Cancer Consortium, Breast Cancer Research Foundation, Simons Foundation, Susan G. Komen Foundation, Prostate Cancer Foundation, CSHL Cancer Center, WSBS Cold Spring Harbor, NY - Seemingly similar cells often have significantly different genomes. This is often true of cancer cells, for example, which may differ one from another even within a small tumor sample, as genetic mutations within the cells spread in staccato-like bursts. Detailed knowledge of these mutations, called copy number variations, in individual cells can point to specific treatment regimens.
The problem is that current techniques for acquiring this knowledge are difficult and produce unreliable results. Today, scientists at Cold Spring Harbor Laboratory (CSHL) publish a new interactive analysis program called Gingko that reduces the uncertainty of single-cell analysis and provides a simple way to visualize patterns in copy number mutations across populations of cells.
The open-source software, which is freely available online, will improve scientists' ability to study this important type of genetic anomaly and could help clinicians better target medications based on cells' specific mutation profiles. The software is described online today in Nature Methods.
Mutations come in many forms. For example, in the most common type of mutation, variations may exist among individual people--or cells--at a single position in a DNA sequence. Another common mutation is a copy number variation (CNV), in which large chunks of DNA are either deleted from or added to the genome. When there are too many or too few copies of a given gene or genes, due to CNVs, disease can occur. Such mutations have been linked not only with cancer but a host of other illnesses, including autism and schizophrenia.
Researchers can learn a lot by analyzing CNVs in bulk samples--from a tumor biopsy, for example--but they can learn more by investigating CNVs in individual cells. "You may think that every cell in a tumor would be the same, but that's actually not the case," says CSHL Associate Professor Michael Schatz.
"We're realizing that there can be a lot of changes inside even a single tumor," says Schatz. "If you're going to treat cancer, you need to diagnose exactly what subclass of cancer you have." Simultaneously employing different drugs to target different cancer subclasses could prevent remission, scientists have proposed.
One powerful single-cell analytic technique for exploring CNV is whole genome sequencing. The challenge is that, before sequencing can be done, the cell's DNA has to be amplified many times over. This process is rife with errors, with some arbitrary chunks of DNA being amplified more than others. In addition, because many labs use their own software to examine CNVs, there is little consistency in how researchers analyze their results.
To address these two challenges, Schatz and his colleagues created Gingko. The interactive, web-based program automatically processes sequence data, maps the sequences to a reference genome, and creates CNV profiles for every cell that can then be viewed with a user-friendly graphical interface. In addition, Gingko constructs phylogenetic trees based on the profiles, allowing cells with similar copy number mutations to be grouped together.
Importantly, Gingko, which Schatz and his colleagues validated by reproducing the findings of five major single-cell studies, also analyzes patterns in the sequence reads in order to recognize, and greatly reduce, amplification errors.
Schatz and his team named their software after the gingko tree, which has many well-documented therapeutic benefits. "We like to think our Gingko 'trees' will provide benefits as well," says Schatz, referring to the graphical way that CNV changes are represented by analysts. Right now, CNV is not a commonly used diagnostic measurement in the clinic. "We're looking into the best way of collecting samples, analyzing them, and informing clinicians about the results," says Schatz. He adds that CSHL has collaborations with many hospitals, notably Memorial Sloan Kettering Cancer Center and the North Shore-LIJ Health System, to bring single-cell analysis to the clinic.
For Schatz, Gingko represents a culmination of CSHL's efforts over the past decade--spearheaded by CSHL Professor Michael Wigler--to pioneer techniques for studying single cells. "Cold Spring Harbor has established itself as the world leader in single-cell analysis," says Schatz. "We've invented many of the technologies and techniques important to the field and now we've taken all this knowledge and bundled it up so that researchers around the world can take advantage of our expertise."
INFORMATION:
The research described in the release was supported by the National Institutes of Health (NIH), the National Science Foundation, the Starr Cancer Consortium, the Breast Cancer Research Foundation, the Simons Foundation, the Susan G. Komen Foundation, the Prostate Cancer Foundation, the Cold Spring Harbor Laboratory (CSHL) Cancer Center and the Watson School of Biological Sciences at CSHL through an NIH training grant.
"Interactive analysis and assessment of single-cell copy-number variations," appears online September 7, 2015 in Nature Methods. The authors are Tyler Garvin, Robert Aboukhalil, Jude Kendall, Timour Baslan, Gurinder S. Atwal, James Hicks, Michael Wigler and Michael C. Schatz. The paper can be viewed at: http://nature.com/articles/doi:10.1038/nmeth.3578
About Cold Spring Harbor Laboratory
Celebrating its 125th anniversary in 2015, Cold Spring Harbor Laboratory has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology. Home to eight Nobel Prize winners, the private, not-for-profit Laboratory is more than 600 researchers and technicians strong. The Meetings & Courses Program hosts more than 12,000 scientists from around the world each year on its campuses in Long Island and in Suzhou, China. The Laboratory's education arm also includes an academic publishing house, a graduate school and programs for middle and high school students and teachers. For more information, visit http://www.cshl.edu
Scientists at the University of Cambridge University have published new results in the journal PLoS ONE from the largest ever study of people with autism taking the 'Reading the Mind in the Eyes' test. Whilst typical adults showed the predicted and now well-established sex difference on this test, with women on average scoring higher than men, in adults with autism this typical sex difference was conspicuously absent. Instead, both men and women with autism showed an extreme of the typical male pattern on the test, providing strong support for the 'extreme male brain' theory ...
A 'gene signature' that could be used to predict the onset of diseases, such as Alzheimer's, years in advance has been developed in research published in the open access journal Genome Biology.
The study aimed to define a set of genes associated with 'healthy ageing' in 65 year olds. Such a molecular profile could be useful for distinguishing people at earlier risk of age-related diseases. This could improve upon the use of chronological age and complement traditional indicators of disease, such as blood pressure.
Lead author James Timmons, from King's College London, ...
A study led by Dr. Bing Hu at Plymouth University Peninsula Schools of Medicine and Dentistry and involving other researchers from China and Switzerland, suggests for the first time that the use of local anaesthetic may affect tooth cell growth and the development of children's teeth.
The study is published today, Monday 7th September 2015, in Cell Death Discovery, a new leading translational medical research journal from Nature Publishing Group, and comes at a time when more children than ever before are subjected to dental surgery - and local anaesthetic - because of ...
A highly effective drug that helps smokers to quit does not increase their risk of heart attack and depression as was previously thought, research suggests.
Researchers who carried out the study say doctors can prescribe varenicline - also known as Champix™ or ChantixTM - more widely to help people stop smoking.
Varenicline is the most effective medication to help smokers quit but previous reports have suggested that users may be more likely to suffer a heart attack.
The drug has also been linked to depression, self-harm and suicide.
This latest research ...
Fewer patients are admitted at weekends, but are more likely to be sicker and have a higher risk of death from Friday through until Monday
Authors caution against using the data to estimate avoidable deaths, but call for more research into how services can be improved to reduce risk
Patients admitted to hospital at the weekend are more likely to be sicker and have a higher risk of death, compared with those admitted during the week, finds an analysis published in The BMJ this week.
The analysis was carried out as a collaboration between University Hospital Birmingham ...
Action to prevent tooth decay in children, such as supervised tooth brushing and fluoride varnish schemes, are not just beneficial to children's oral health but could also result in cost savings to the NHS of hundreds of pounds per child, so says a leading dental health researcher.
Professor Elizabeth Kay, Foundation Dean of the Peninsula Dental School from Plymouth University Peninsula Schools of Medicine and Dentistry, has carried out the first economic evaluation of public health measures to reduce tooth decay in children at high risk, in association with the National ...
An international team of scientists has developed what may be the first one-step process for making seamless carbon-based nanomaterials that possess superior thermal, electrical and mechanical properties in three dimensions.
The research holds potential for increased energy storage in high efficiency batteries and supercapacitors, increasing the efficiency of energy conversion in solar cells, for lightweight thermal coatings and more. The study is published today (Sept. 4) in the online journal Science Advances.
In early testing, a three-dimensional (3D) fiber-like ...
Washington, DC - September 4, 2015 - Decontamination protocols eradicated both methicillin-resistant Staphylococcus aureus (MRSA) and antibiotic resistant, pathogenic intestinal bacteria, the Enterobacteriaceae, from a pig farm. The research appears online September 4th in ASM's journal Applied and Environmental Microbiology.
The study involved a farm on which both pathogens had been discovered through routine monitoring. The farmer had approached the investigators for help. The Enterobacteriaceae were expressing resistance genes called extended-spectrum β-lactamases ...
WINSTON-SALEM, N.C. - Sept. 4, 2015 - A commonly prescribed antidepressant may alter brain structures in depressed and non-depressed individuals in very different ways, according to new research at Wake Forest Baptist Medical Center.
The study - conducted in nonhuman primates with brain structures and functions similar to those of humans - found that the antidepressant sertraline, a selective serotonin reuptake inhibitor (SSRI) marketed as Zoloft, significantly increased the volume of one brain region in depressed subjects but decreased the volume of two brain areas in ...
Far above the wildfires raging in Washington's forests, a less noticeable consequence of this dry year is taking place in mountain ponds. The minimal snowpack and long summer drought that have left the Pacific Northwest lowlands parched also affect the region's amphibians due to loss of mountain pond habitat.
According to a new paper published Sept. 2 in the open-access journal PLOS ONE, this summer's severe conditions may be the new normal within just a few decades.
"This year is an analog for the 2070s in terms of the conditions of the ponds in response to climate," ...
